Michael Rader

3.3k citations
20 papers · 2.4k · 2 hit papers · h-index 9

Impact in

Papers in

    • Bone health and treatments 6
    • Neutropenia and Cancer Infections 6
    • Cancer Treatment and Pharmacology 3
    • Blood disorders and treatments 6

Michael Rader

19 papers receiving 2.3k citations

Michael Rader's Hit Papers

Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials 2012 · 428 citations
4280+5+10Years since publication4008001.2k

Peers

Michael Rader
Comparison fields: 5 of 69
  • Oncology 1.6k
  • Orthopedics and Sports Medicine 273
  • Pulmonary and Respiratory Medicine 769
  • Radiology, Nuclear Medicine and Imaging 438
  • Cancer Research 167
Replace Richard H. De Boer with:
Richard H. De Boer Australia
Ada Braun United States
Alan Keller United States
Lawrence I. Karsh United States
H.P. Sleeboom Netherlands
Brigitte Mlineritsch Austria
Sarah Taylor United States
Rodolfo Bordoni United States
Winnie Sohn United States
Joseph W. Leach United States
Michael Rader relative to Richard H. De Boer Australia Richard H. De Boer's profile →
Citations per field
00.5×1.7×
Richard H. De Boer · 1×
Citations per year

Countries citing papers authored by Michael Rader

Since Specialization
Citations

This map shows the geographic impact of Michael Rader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Rader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Rader more than expected).

Fields of papers citing papers by Michael Rader

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Rader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Rader. The network helps show where Michael Rader may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Rader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Rader Line = papers co-authored together Michael Rader links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
Hit paper breakdown →
20111390
2
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
Hit paper breakdown →
2012428
3 1989271
4 2014113
5 200953
6 201249
7 200742
8 197415
9
Granulocyte colony-stimulating factor use in patients with chemotherapy-induced neutropenia: clinical and economic benefits.
200612
10 20116
11 20124
12 20004
13 20103
14 20052
15 20112
16
Final results of a large, community-based, prospective study evaluating the impact of first and subsequent cycle pegfilgrastim on neutropenic events in patients receiving myelosuppressive chemotherapy
20071
17 20121
18 20071
19
Two Heads Are Better Than One: Collaborative Development of an Online Course Content Template
20101
20 20060

About Michael Rader

Michael Rader is a scholar working on Oncology, Genetics, Pulmonary and Respiratory Medicine, Molecular Biology and Dermatology, having authored 20 papers that have together received 2.4k indexed citations. Recurring topics across this work include Bone health and treatments (6 papers), Blood disorders and treatments (6 papers), Neutropenia and Cancer Infections (6 papers), Cancer Treatment and Pharmacology (3 papers), Prostate Cancer Treatment and Research (2 papers), Chemotherapy-related skin toxicity (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Medical Imaging and Pathology Studies (1 paper). The work is most often cited by research in Oncology (1.6k citations), Orthopedics and Sports Medicine (273 citations), Pulmonary and Respiratory Medicine (769 citations), Radiology, Nuclear Medicine and Imaging (438 citations) and Cancer Research (167 citations). Michael Rader has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Karim Fizazi, Janet E. Brown, Huei Wang, Neal D. Shore, Carsten Goessl, Michael A. Carducci, Ronaldo Damião, Piotr Milecki, Lawrence I. Karsh and Roger Dansey. Their work appears in journals such as Journal of Clinical Oncology, European Urology, European Journal of Cancer, The Lancet and Quality of Life Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact